PRESENTING COMPANIES 2026
DNB Carnegie | Back Bay is proud to invite US and Nordic life science companies with exceptional technologies or advances to present at the 10th Annual Nordic-American Healthcare Conference.
Over the years, NAHC presenting companies have showcased cutting-edge technologies designed to address critical unmet needs in disease treatment and significantly advance healthcare delivery.
The following companies will present their healthcare technologies/updates at NAHC 2026:
-
AddLife (OM:ALIF B)
SWEDEN
Diagnostics/Commercial
Presented by:
Fredrik Dalborg, Chief Executive Officer
Company Information > -
ALK (CPSE:ALK B)
DENMARK
Immunology/Commercial
Presented by:
Per Plotnikof Vice President Corporate Communications, Investor Relations and Strategic Planning
Company Information > -
Ambu (CPSE:AMBU B)
DENMARK
Diagnostics/Commercial
Presented by:
Anders Hjort, Head of Investor Relations
Company Information > -
BioArctic (OM:BIOA B)
SWEDEN
Neurology/Commercial
Presented by:
Oskar Bosson
VP, Head of IR & Communication
Company Information > -
BioGaia
SWEDEN
Probiotics/Commercial
Presented by: Theresa Agnew, Chief Executive Officer and President
Company Information > -
BioInvent
SWEDEN
Oncology/Clinical
Presented by:
Martin Welschof, Chief Executive Officer
Company Information > -
Bonesupport (OM:BONEX)
SWEDEN
Orthopedics/Commercial
Presented by:
Torbjörn Sköld, Chief Executive Officer
Håkan Johansson, Chief Financial Officer
Company Information > -
Camurus (OM:CAMX)
SWEDEN
CNS/Pain, Commercial
Presented by:
Fredrik Tiberg, President & Chief Executive Officer
Company Information > -
Embla Medical (CPSE:EMBLA)
ICELAND
Orthopedics/Commercial
Presented by:
Sveinn Sölvason, President and CEO
Company Information > -
F2G (Private)
US-UK
Rare/Fungal/Commercial
Presented by:
Francesco Maria Lavino, Chief Executive Officer
Company Information > -
Humacyte (NASDAQ: HUMA)
UNITED STATES
Cardiovascular/Commercial
Presented by:
Laura Niklason, Founder, President and Chief Executive Officer
Company Information > -
Ironwood Pharmaceuticals (NASDAQ: IRWD)
UNITED STATES
Rare/Commercial
Presented by:
Tammi Gaskins, Chief Commercial Officer
Company Information > -
Ligand Pharmaceuticals
UNITED STATES
Biopharma Development/Commercial
Presented by:
Paul J. Hadden, Senior Vice President, Investments and Business Development
Company Information > -
Lundbeck (CPSE:HLUN B)
DENMARK
Neurology/Commercial
Presented by:
Johan Luthman, Executive Vice President, R&D
Company Information > -
Medistim (MEDI.OL)
NORWAY
Cardio/Surgery/Commercial
Presented by:
Kari Eian Krogstad, Chief Executive Officer
Company Information > -
NewAmsterdam Pharma (NASDAQGM:NAMS)
NETHERLANDS
Diagnostics/Phase III
Presented by:
Michael Davidson, Chief Executive Officer
Company Information > -
NMD Pharma (Private)
DENMARK
Neurology/Phase II
Presented by:
Thomas Holm Pedersen, Chief Executive Officer
Company Information > -
Novo Nordisk (CPSE:NOVO B)
DENMARK
Metabolic/Commercial
Presented by:
Frederik Taylor Pitter Investor Relations Director, North America
Company Information > -
Orion (HLSE:ORNBV)
FINLAND
Oncology, CNS/Pain/Commerical
Presented by:
Tuukka Hirvonen, Head of Investor Relations
Company Information > -
Photocure (OB:PHO)
NORWAY
Diagnostics/Commercial
Presented by:
Dan Schneider, President and Chief Executive Officer
Company Information > -
Pulse BioSciences (NASDAQCM:PLSE)
UNITED STATES
Dermatology/Commercial
Presented by:
Paul LaViolette, Chief Executive Officer & Co-Chairman of the Board of Directors
Company Information > -
Saniona
SWEDEN
CNS/Commercial
Presented by:
Thomas Feldthus, Chief Executive Officer -
SOBI (OM:SOBI)
SWEDEN
Hematology/Commercial
Presented by:
Duane H. Barnes, President, Head of Sobi North America
Company Information > -
Vicore Pharma (OM:VICO)
SWEDEN
Respiratory/Phase II
Presented by:
Megan Richards, Vice President of Investor Relations
Company Information > -
Vitrolife (OM:VITR)
SWEDEN
Women’s Health/Commercial
Presented by:
Pär Ihrskog, Chief Financial Officer
Company Information > -
XVIVO (OM:XVIVO)
SWEDEN
Organ Transplant/Commerical
Presented by:
Kristoffer Nordström, Chief Financial Officer
Company Information >